Related Experiment Video
Updated: Jan 8, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Mild Reduction-Mediated NK Cell Membrane Modification for ROS Scavenging Efficacy Overcome Immunosuppressive Tumor
Kyung Mu Noh1, Jaewon Park1, Sungjun Kim1
1Department of Chemical & Biochemical Engineering, Dongguk University, Seoul, Republic of Korea.
Abstract:
Solid tumors are characterized by a metabolically dysregulated tumor microenvironment (TME) enriched with reactive oxygen species (ROS), which suppresses immune cell function. Natural killer (NK) cells are promising effectors in cancer immunotherapy due to their intrinsic cytotoxicity without prior antigen sensitization. However, oxidative stress impairs NK cell cytotoxicity by reducing degranulation, interferon-γ production, and survival. Therefore, maintaining NK cell redox balance is a crucial obstacle to achieving optimal therapeutic results in ROS-rich TMEs. Here, we proposed a straightforward, non-genetic ex vivo membrane modification approach to reinforce the redox balance of NK cells via ROS scavenging. Using tris(2-carboxyethyl)phosphine (TCEP), a mild reducing agent, we selectively introduced free thiol groups onto the exterior surface of NK cell plasma membranes. The engineered surface-thiol-riched NK cells (STR-NK) demonstrated (1) increased membrane thiols, (2) efficiently eliminated extracellular ROS, (3) attenuated intracellular ROS accumulation, and (4) preserved cytotoxicity-associated gene expression under oxidative stress. Importantly, STR-NK cells maintained potent cytotoxicity against diverse solid tumor cells despite the presence of ROS. Overall, this uncomplicated and scalable surface redox modulation approach enhances NK cell anticancer activity under oxidative stress, offering a promising strategy to improve NK cell-based cancer immunotherapies in ROS-enriched solid TMEs.
Insights
This study engineered natural killer (NK) cells to scavenge reactive oxygen species (ROS) in solid tumors. Modified NK cells show enhanced anti-cancer activity in ROS-rich tumor microenvironments.
Area of Science:
- Immunology
- Cancer Biology
- Biotechnology
Background:
- Solid tumors feature a tumor microenvironment (TME) with high reactive oxygen species (ROS) that impair immune cell function.
- Natural killer (NK) cells are vital for cancer immunotherapy but their efficacy is reduced by oxidative stress in the TME.
- Maintaining NK cell redox balance is critical for effective cancer immunotherapy in ROS-rich TMEs.
Purpose of the Study:
- To develop a method for reinforcing NK cell redox balance to enhance their anti-cancer activity.
- To investigate the potential of ex vivo membrane modification for improving NK cell function in oxidative stress conditions.
Main Methods:
- Engineered NK cells by introducing surface thiol groups using tris(2-carboxyethyl)phosphine (TCEP) for ROS scavenging.
- Assessed ROS scavenging capacity, intracellular ROS levels, and cytotoxicity-associated gene expression in engineered NK cells (STR-NK).
- Evaluated the cytotoxic activity of STR-NK cells against solid tumor cells in the presence of ROS.
Main Results:
- Surface-thiol-riched NK cells (STR-NK) exhibited increased membrane thiols and efficient extracellular ROS elimination.
- STR-NK cells demonstrated attenuated intracellular ROS accumulation and preserved cytotoxicity-associated gene expression under oxidative stress.
- Engineered NK cells maintained potent cytotoxicity against solid tumor cells in ROS-rich conditions.
Conclusions:
- A straightforward, scalable ex vivo membrane modification approach enhances NK cell redox balance and anti-cancer activity.
- This strategy offers a promising method to improve NK cell-based immunotherapies in ROS-enriched solid TMEs.
- Surface redox modulation of NK cells represents a viable approach to overcome oxidative stress-induced immune suppression in cancer.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy

